INSIDE TRACK: NGS Takes the Big Leap
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
Read More
Search Results for: liver disease
NanoString Announces Availability and Adoption of Prosigna Breast Cancer Assay
NanoString Technologies has announced nationwide availability of its Prosigna breast cancer prognostic gene signature assay beginning in the first quarter of 2014. Initial adopters include ARUP Laboratories, LabCorp, and Quest Diagnostics.
Read MoreNew York Approves Use of Prenatal Testing Portfolio by Natera
The New York State Department of Health has issued a clinical laboratory permit for Natera, of San Carlos, Calif, enabling the company to make its portfolio of preconception and prenatal tests available to expecting parents in New York State.
Read MoreBiodesix Pulls in $8 Million in New Financing
Molecular diagnostics company Biodesix announced that it has closed $8.4 million in Series E financing. The capital will help develop the company’s mass-spec technology platform and market the company’s first test, VeriStat, to guide NSCLC therapy.
Read More
New Test Facilitates Early Diagnosis of Liver Cancer
Researchers have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue.
Read More